W Trademark
Trademark Overview
On Tuesday, January 9, 2024, a trademark application was filed for W with the United States Patent and Trademark Office. The USPTO has given the W trademark a serial number of 98349163. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 3, 2024. This trademark is owned by Wave Life Sciences Ltd.. The W trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders
Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals
General Information
| Serial Number | 98349163 |
| Word Mark | W |
| Filing Date | Tuesday, January 9, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the stylized letter "W" in gradient shades of dark blue to light blue and dark purple to pink. |
| Goods and Services | Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders |
| Pseudo Mark | WAVE |
| Indication of Colors claimed | The color(s) dark blue, light blue, dark purple, and pink is/are claimed as a feature of the mark. |
| Goods and Services | Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 9, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 9, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Wave Life Sciences Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Singapore 018936
SG |
| Party Name | Wave Life Sciences Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Singapore 018936
SG |
Trademark Events
| Event Date | Event Description |
| Sunday, April 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 5, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 7, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 7, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 6, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 9, 2024 | NEW APPLICATION ENTERED |
